TreeWAS – Variant ID: rs7082237

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C83.3 Large cell (diffuse)	0.047	0.953	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.025	0.975	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.019	0.981	0.000
C83.1 Small cleaved cell (diffuse)	0.019	0.981	0.000
C83.7 Burkitt's tumour	0.018	0.982	0.000
C83.6 Undifferentiated (diffuse)	0.018	0.982	0.000
C83.5 Lymphoblastic (diffuse)	0.018	0.982	0.000
C83.4 Immunoblastic (diffuse)	0.018	0.982	0.000
C83.2 Mixed small and large cell (diffuse)	0.018	0.982	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.017	0.983	0.000
C83.0 Small cell (diffuse)	0.016	0.984	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.015	0.985	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.015	0.985	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.014	0.986	0.000
N18.3 Chronic kidney disease, stage 3	0.000	0.986	0.014
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.013	0.987	0.000
C82.2 Large cell, follicular	0.012	0.988	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.011	0.988	0.000
C82.3 Follicular lymphoma grade IIIa	0.011	0.989	0.000
C82.6 Cutaneous follicle centre lymphoma	0.011	0.989	0.000
C82.5 Diffuse follicle centre lymphoma	0.011	0.989	0.000
C82.4 Follicular lymphoma grade IIIb	0.011	0.989	0.000
C82.0 Small cleaved cell, follicular	0.011	0.989	0.000
C86 Other specified types of T/NK-cell lymphoma	0.011	0.989	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.010	0.990	0.000
C95 Leukaemia of unspecified cell type	0.010	0.990	0.000
C94 Other leukaemias of specified cell type	0.010	0.990	0.000
C93 Monocytic leukaemia	0.010	0.990	0.000
F45.8 Other somatoform disorders	0.010	0.990	0.000
C88 Malignant immunoproliferative diseases	0.009	0.990	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.009	0.990	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.009	0.991	0.000
C81 Hodgkin's disease	0.009	0.991	0.000
N18 Chronic renal failure	0.000	0.991	0.009
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.009	0.991	0.000
N18.5 Chronic kidney disease, stage 5	0.000	0.992	0.008
N18.4 Chronic kidney disease, stage 4	0.000	0.992	0.008
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.008	0.992	0.000
C86.4 Blastic NK-cell lymphoma	0.008	0.992	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.008	0.992	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.008	0.992	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.008	0.992	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.008	0.992	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.008	0.992	0.000
C91 Lymphoid leukaemia	0.007	0.992	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.007	0.993	0.000
C93.9 Monocytic leukaemia, unspecified	0.007	0.993	0.000
C93.7 Other monocytic leukaemia	0.007	0.993	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.007	0.993	0.000
C93.2 Subacute monocytic leukaemia	0.007	0.993	0.000
C93.1 Chronic monocytic leukaemia	0.007	0.993	0.000
C93.0 Acute monocytic leukaemia	0.007	0.993	0.000
C94.7 Other specified leukaemias	0.007	0.993	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.007	0.993	0.000
C94.5 Acute myelofibrosis	0.007	0.993	0.000
C94.4 Acute panmyelosis	0.007	0.993	0.000
C94.3 Mast cell leukaemia	0.007	0.993	0.000
C94.2 Acute megakaryoblastic leukaemia	0.007	0.993	0.000
C94.1 Chronic erythraemia	0.007	0.993	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.007	0.993	0.000
C95.9 Leukaemia, unspecified	0.007	0.993	0.000
C95.7 Other leukaemia of unspecified cell type	0.007	0.993	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.007	0.993	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.007	0.993	0.000
C95.0 Acute leukaemia of unspecified cell type	0.007	0.993	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.007	0.993	0.000
C96.8 Histiocytic sarcoma	0.007	0.993	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.007	0.993	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.007	0.993	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.007	0.993	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.007	0.993	0.000
C96.3 True histiocytic lymphoma	0.007	0.993	0.000
C96.2 Malignant mast cell tumour	0.007	0.993	0.000
C96.1 Malignant histiocytosis	0.007	0.993	0.000
C96.0 Letterer-Siwe disease	0.007	0.993	0.000
N18.0 End-stage renal disease	0.000	0.993	0.007
C81.0 Lymphocytic predominance	0.007	0.993	0.000
C84.4 Peripheral T-cell lymphoma	0.007	0.993	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.007	0.993	0.000
C88.7 Other malignant immunoproliferative diseases	0.007	0.993	0.000
C88.3 Immunoproliferative small intestinal disease	0.007	0.993	0.000
C88.2 Gamma heavy chain disease	0.007	0.993	0.000
C88.1 Alpha heavy chain disease	0.007	0.993	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.007	0.993	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.007	0.993	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.007	0.993	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.007	0.993	0.000
C84.3 Lymphoepithelioid lymphoma	0.007	0.993	0.000
C84.2 T-zone lymphoma	0.007	0.993	0.000
C84.1 Sezary's diease	0.007	0.993	0.000
C84.0 Mycosis fungoides	0.007	0.993	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.007	0.993	0.000
C81.7 Other Hodgkin's disease	0.007	0.993	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.007	0.993	0.000
C81.3 Lymphocytic depletion	0.007	0.993	0.000
C81.2 Mixed cellularity	0.007	0.993	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.006	0.993	0.000
Z09.9 Follow-up examination after unspecified treatment for other conditions	0.000	0.993	0.007
C84.5 Other and unspecified T-cell lymphomas	0.006	0.993	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.006	0.993	0.000
C85.0 Lymphosarcoma	0.006	0.993	0.000
C91.0 Acute lymphoblastic leukaemia	0.006	0.994	0.000
C81.1 Nodular sclerosis	0.006	0.994	0.000
N18.1 Chronic kidney disease, stage 1	0.000	0.994	0.006
H72.8 Other perforations of tympanic membrane	0.006	0.994	0.000
F45 Somatoform disorders	0.006	0.994	0.000
H61.0 Perichondritis of external ear	0.000	0.994	0.006
C85.1 B-cell lymphoma, unspecified	0.006	0.994	0.000
C92 Myeloid leukaemia	0.006	0.994	0.000
N80.1 Endometriosis of ovary	0.000	0.994	0.006
C90.2 Plasmacytoma, extramedullary	0.006	0.994	0.000
C90.3 Solitary plasmacytoma	0.006	0.994	0.000
C90.1 Plasma cell leukaemia	0.006	0.994	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.005	0.994	0.000
C91.7 Other lymphoid leukaemia	0.005	0.994	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.005	0.994	0.000
C91.5 Adult T-cell leukaemia	0.005	0.994	0.000
C91.3 Prolymphocytic leukaemia	0.005	0.994	0.000
C91.2 Subacute lymphocytic leukaemia	0.005	0.994	0.000
N83.2 Other and unspecified ovarian cysts	0.000	0.994	0.006
C91.9 Lymphoid leukaemia, unspecified	0.005	0.995	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.005	0.995	0.000
H61 Other disorders of external ear	0.000	0.995	0.005
F45.3 Somatoform autonomic dysfunction	0.005	0.995	0.000
N18.2 Chronic kidney disease, stage 2	0.000	0.995	0.005
N18.8 Other chronic renal failure	0.000	0.995	0.005
C91.4 Hairy-cell leukaemia	0.005	0.995	0.000
C81.9 Hodgkin's disease, unspecified	0.005	0.995	0.000
F45.0 Somatisation disorder	0.005	0.995	0.000
H61.9 Disorder of external ear, unspecified	0.000	0.995	0.005
H61.2 Impacted cerumen	0.000	0.995	0.005
H72.0 Central perforation of tympanic membrane	0.005	0.995	0.000
F45.9 Somatoform disorder, unspecified	0.005	0.995	0.000
F45.4 Persistent somatoform pain disorder	0.005	0.995	0.000
F45.2 Hypochondriacal disorder	0.005	0.995	0.000
F45.1 Undifferentiated somatoform disorder	0.005	0.995	0.000
C92.9 Myeloid leukaemia, unspecified	0.004	0.995	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.004	0.995	0.000
C92.7 Other myeloid leukaemia	0.004	0.995	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.004	0.995	0.000
C92.5 Acute myelomonocytic leukaemia	0.004	0.995	0.000
C92.4 Acute promyelocytic leukaemia	0.004	0.995	0.000
C92.3 Myeloid sarcoma	0.004	0.995	0.000
C92.2 Subacute myeloid leukaemia	0.004	0.995	0.000
H61.1 Non-infective disorders of pinna	0.000	0.996	0.004
R45.8 Other symptoms and signs involving emotional state	0.004	0.996	0.000
S32.00 Fracture of lumbar vertebra (closed)	0.000	0.996	0.004
H61.8 Other specified disorders of external ear	0.000	0.996	0.004
Z46.6 Fitting and adjustment of urinary device	0.004	0.996	0.000
H72 Perforation of tympanic membrane	0.004	0.996	0.000
N18.9 Chronic renal failure, unspecified	0.000	0.996	0.004
T36-T50 Poisoning by drugs, medicaments and biological substances	0.004	0.996	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.004	0.996	0.000
T39.1 4-Aminophenol derivatives	0.004	0.996	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.004	0.996	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.004	0.996	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.004	0.996	0.000
H74.3 Other acquired abnormalities of ear ossicles	0.004	0.996	0.000
T36 Poisoning by systemic antibiotics	0.004	0.996	0.000
H60.9 Otitis externa, unspecified	0.000	0.996	0.004
H60-H62 Diseases of external ear	0.000	0.996	0.003
Z46.8 Fitting and adjustment of other specified devices	0.004	0.996	0.000
H61.3 Acquired stenosis of external ear canal	0.000	0.996	0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.996	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.003	0.997	0.000
H66.9 Otitis media, unspecified	0.003	0.997	0.000
H60 Otitis externa	0.000	0.997	0.003
H72.1 Attic perforation of tympanic membrane	0.003	0.997	0.000
N50.8 Other specified disorders of male genital organs	0.003	0.997	0.000
N80.0 Endometriosis of uterus	0.000	0.997	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.997	0.000
T42.0 Hydantoin derivatives	0.003	0.997	0.000
Z50.9 Care involving use of rehabilitation procedure, unspecified	0.000	0.997	0.003
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T42.1 Iminostilbenes	0.003	0.997	0.000
T36.0 Penicillins	0.003	0.997	0.000
T40.6 Other and unspecified narcotics	0.003	0.997	0.000
W29.9 Unspecified place	0.003	0.997	0.000
R22.2 Localised swelling, mass and lump, trunk	0.000	0.997	0.003
H66 Suppurative and unspecified otitis media	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.997	0.000
C92.0 Acute myeloid leukaemia	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
T43.6 Psychostimulants with abuse potential	0.003	0.997	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.003	0.997	0.000
T39.2 Pyrazolone derivatives	0.003	0.997	0.000
T39.0 Salicylates	0.003	0.997	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.003	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
C90.0 Multiple myeloma	0.003	0.997	0.000
T43.9 Psychotropic drug, unspecified	0.003	0.997	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
N50.1 Vascular disorders of male genital organs	0.003	0.997	0.000
N80 Endometriosis	0.000	0.997	0.003
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.003	0.997	0.000
H65-H75 Diseases of middle ear and mastoid	0.003	0.997	0.000
H66.1 Chronic tubotympanic suppurative otitis media	0.003	0.997	0.000
K90.0 Coeliac disease	0.003	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
H72.2 Other marginal perforations of tympanic membrane	0.003	0.997	0.000
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.000	0.997	0.003
C92.1 Chronic myeloid leukaemia	0.003	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
T46.7 Peripheral vasodilators	0.003	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.003	0.997	0.000
Z46 Fitting and adjustment of other devices	0.003	0.997	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.003	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.997	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.003	0.997	0.000
T42.3 Barbiturates	0.003	0.997	0.000
T42.2 Succinimides and oxazolidinediones	0.003	0.997	0.000
H66.2 Chronic atticoantral suppurative otitis media	0.003	0.997	0.000
N80.8 Other endometriosis	0.000	0.997	0.003
N50 Other disorders of male genital organs	0.003	0.997	0.000
C91.1 Chronic lymphocytic leukaemia	0.003	0.997	0.000
N83.0 Follicular cyst of ovary	0.000	0.997	0.003
T36.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
T36.8 Other systemic antibiotics	0.003	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
T36.6 Rifamycins	0.003	0.997	0.000
T36.5 Aminoglycosides	0.003	0.997	0.000
T36.4 Tetracyclines	0.003	0.997	0.000
T36.3 Macrolides	0.003	0.997	0.000
T36.2 Chloramphenicol group	0.003	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.997	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
H74 Other disorders of middle ear and mastoid	0.003	0.997	0.000
H62 Disorders of external ear in diseases classified elsewhere	0.000	0.997	0.003
R45 Symptoms and signs involving emotional state	0.003	0.997	0.000
H60.5 Acute otitis externa, non-infective	0.000	0.997	0.003
N83.5 Torsion of ovary, ovarian pedicle and Fallopian tube	0.000	0.997	0.003
D12.0 Caecum	0.000	0.997	0.003
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.003	0.997	0.000
T40.8 Lysergide [LSD]	0.003	0.997	0.000
T40.7 Cannabis (derivatives)	0.003	0.997	0.000
T40.5 Cocaine	0.003	0.997	0.000
T40.3 Methadone	0.003	0.997	0.000
T40.1 Heroin	0.003	0.997	0.000
T40.0 Opium	0.003	0.997	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
H60.4 Cholesteatoma of external ear	0.000	0.997	0.003
H60.2 Malignant otitis externa	0.000	0.997	0.003
H60.0 Abscess of external ear	0.000	0.997	0.003
T43.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
T40.2 Other opioids	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.997	0.000
T47.5 Digestants	0.003	0.997	0.000
T47.4 Other laxatives	0.003	0.997	0.000
T47.3 Saline and osmotic laxatives	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.003	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.997	0.000
H60.1 Cellulitis of external ear	0.000	0.997	0.003
T43.2 Other and unspecified antidepressants	0.003	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.997	0.000
T37.5 Antiviral drugs	0.002	0.997	0.000
T37.4 Anthelminthics	0.002	0.997	0.000
T37.3 Other antiprotozoal drugs	0.002	0.997	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.997	0.000
T37.1 Antimycobacterial drugs	0.002	0.997	0.000
T37.0 Sulphonamides	0.002	0.997	0.000
T50.8 Diagnostic agents	0.002	0.997	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.997	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.997	0.000
T50.5 Appetite depressants	0.002	0.997	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.997	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.997	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.997	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.997	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.997	0.000
U51.1 Previously admitted to a psychiatric hospital of the provider	0.000	0.997	0.003
H60.8 Other otitis externa	0.000	0.997	0.003
H74.1 Adhesive middle ear disease	0.003	0.997	0.000
R45.4 Irritability and anger	0.003	0.997	0.000
H60.3 Other infective otitis externa	0.000	0.997	0.002
N83.9 Noninflammatory disorder of ovary, Fallopian tube and broad ligament, unspecified	0.000	0.997	0.003
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium	0.000	0.997	0.003
H69 Other disorders of Eustachian tube	0.003	0.997	0.000
N50.9 Disorder of male genital organs, unspecified	0.003	0.997	0.000
T41.5 Therapeutic gases	0.002	0.997	0.000
T41.4 Anaesthetic, unspecified	0.002	0.997	0.000
T41.3 Local anaesthetics	0.002	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.997	0.000
T41.1 Intravenous anaesthetics	0.002	0.997	0.000
T41.0 Inhaled anaesthetics	0.002	0.997	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.997	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.997	0.000
T48.5 Anti-common-cold drugs	0.002	0.997	0.000
T48.4 Expectorants	0.002	0.997	0.000
T48.3 Antitussives	0.002	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.997	0.000
T48.0 Oxytocic drugs	0.002	0.997	0.000
T49.9 Topical agent, unspecified	0.002	0.997	0.000
T49.8 Other topical agents	0.002	0.997	0.000
T49.7 Dental drugs, topically applied	0.002	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.997	0.000
T49.2 Local astringents and local detergents	0.002	0.997	0.000
T49.1 Antipruritics	0.002	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.997	0.000
H66.0 Acute suppurative otitis media	0.002	0.997	0.000
I49.5 Sick sinus syndrome	0.003	0.997	0.000
R45.7 State of emotional shock and stress, unspecified	0.002	0.997	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.997	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.997	0.000
T44.0 Anticholinesterase agents	0.002	0.997	0.000
H65.3 Chronic mucoid otitis media	0.000	0.997	0.002
R45.5 Hostility	0.002	0.997	0.000
T46.1 Calcium-channel blockers	0.002	0.997	0.000
Z46.4 Fitting and adjustment of orthodontic device	0.002	0.997	0.000
H66.4 Suppurative otitis media, unspecified	0.002	0.997	0.000
N80.2 Endometriosis of Fallopian tube	0.000	0.997	0.002
T40.4 Other synthetic narcotics	0.002	0.998	0.000
N80.6 Endometriosis in cutaneous scar	0.000	0.998	0.002
N80.4 Endometriosis of rectovaginal septum and vagina	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.4 Iron and its compounds	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.002	0.998	0.000
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.002	0.998	0.000
H68 Eustachian salpingitis and obstruction	0.002	0.998	0.000
H67 Otitis media in diseases classified elsewhere	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
H69.9 Eustachian tube disorder, unspecified	0.002	0.998	0.000
N83.7 Haematoma of broad ligament	0.000	0.998	0.002
N83.6 Haematosalpinx	0.000	0.998	0.002
N83.4 Prolapse and hernia of ovary and Fallopian tube	0.000	0.998	0.002
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
R45.0 Nervousness	0.002	0.998	0.000
Z46.9 Fitting and adjustment of other unspecified device	0.002	0.998	0.000
Z46.1 Fitting and adjustment of hearing aid	0.002	0.998	0.000
Z46.0 Fitting and adjustment of spectacles and contact lenses	0.002	0.998	0.000
H74.9 Disorder of middle ear and mastoid, unspecified	0.002	0.998	0.000
H70 Mastoiditis and related conditions	0.002	0.998	0.000
H65.1 Other acute nonsuppurative otitis media	0.002	0.998	0.000
Z46.7 Fitting and adjustment of orthopaedic device	0.002	0.998	0.000
H74.2 Discontinuity and dislocation of ear ossicles	0.002	0.998	0.000
S32.0 Fracture of lumbar vertebra	0.000	0.998	0.002
Z46.3 Fitting and adjustment of dental prosthetic device	0.002	0.998	0.000
H62.8 Other disorders of external ear in diseases classified elsewhere	0.000	0.998	0.002
H62.4 Otitis externa in other diseases classified elsewhere	0.000	0.998	0.002
H62.3 Otitis externa in other infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
H62.2 Otitis externa in mycoses	0.000	0.998	0.002
H62.1 Otitis externa in viral diseases classified elsewhere	0.000	0.998	0.002
H62.0 Otitis externa in bacterial diseases classified elsewhere	0.000	0.998	0.002
N50.0 Atrophy of testis	0.002	0.998	0.000
R45.6 Physical violence	0.002	0.998	0.000
D86.9 Sarcoidosis, unspecified	0.002	0.998	0.000
R45.3 Demoralisation and apathy	0.002	0.998	0.000
K80.4 Calculus of bile duct with cholecystitis	0.000	0.998	0.002
H71 Cholesteatoma of middle ear	0.002	0.998	0.000
T42.4 Benzodiazepines	0.002	0.998	0.000
U80.1 Methicillin resistant agent	0.000	0.998	0.002
D86 Sarcoidosis	0.002	0.998	0.000
H65 Nonsuppurative otitis media	0.002	0.998	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.002	0.998	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.998	0.002
Z46.2 Fitting and adjustment of other devices related to nervous system and special senses	0.002	0.998	0.000
U80 Agent resistant to penicillin and related antibiotics	0.000	0.998	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
T45.5 Anticoagulants	0.002	0.998	0.000
T56.8 Other metals	0.002	0.998	0.000
H69.0 Patulous Eustachian tube	0.002	0.998	0.000
U51 Admission status on psychiatric patients	0.000	0.998	0.002
R45.2 Unhappiness	0.002	0.998	0.000
D86.0 Sarcoidosis of lung	0.002	0.998	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.000	0.998	0.002
H67.8 Otitis media in other diseases classified elsewhere	0.002	0.998	0.000
H67.1 Otitis media in viral diseases classified elsewhere	0.002	0.998	0.000
H67.0 Otitis media in bacterial diseases classified elsewhere	0.002	0.998	0.000
H68.1 Obstruction of Eustachian tube	0.002	0.998	0.000
H68.0 Eustachian salpingitis	0.002	0.998	0.000
H69.8 Other specified disorders of Eustachian tube	0.002	0.998	0.000
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere	0.002	0.998	0.000
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.000	0.998	0.002
N83.1 Corpus luteum cyst	0.000	0.998	0.002
O99.5 Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium	0.000	0.998	0.002
N87.1 Moderate cervical dysplasia	0.000	0.998	0.002
W29 Contact with other powered hand tools and household machinery	0.002	0.998	0.000
Z86.1 Personal history of infectious and parasitic diseases	0.000	0.998	0.002
D86.1 Sarcoidosis of lymph nodes	0.002	0.998	0.000
H70.8 Other mastoiditis and related conditions	0.002	0.998	0.000
H70.2 Petrositis	0.002	0.998	0.000
H70.1 Chronic mastoiditis	0.002	0.998	0.000
H70.0 Acute mastoiditis	0.002	0.998	0.000
S32.01 Fracture of lumbar vertebra (open)	0.000	0.998	0.002
N80.5 Endometriosis of intestine	0.000	0.998	0.002
H65.2 Chronic serous otitis media	0.002	0.998	0.000
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.998	0.002
D80.1 Nonfamilial hypogammaglobulinaemia	0.002	0.998	0.000
H74.8 Other specified disorders of middle ear and mastoid	0.002	0.998	0.000
I24.8 Other forms of acute ischaemic heart disease	0.000	0.998	0.002
D86.3 Sarcoidosis of skin	0.002	0.998	0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.000	0.998	0.002
H65.0 Acute serous otitis media	0.001	0.998	0.000
H70.9 Mastoiditis, unspecified	0.002	0.998	0.000
H73 Other disorders of tympanic membrane	0.002	0.998	0.000
O99.4 Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium	0.000	0.998	0.002
D80 Immunodeficiency with predominantly antibody defects	0.002	0.998	0.000
B37.0 Candidal stomatitis	0.002	0.998	0.000
O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium	0.000	0.998	0.002
U51.2 Previously admitted to a psychiatric hospital of another provider	0.000	0.998	0.002
H74.0 Tympanosclerosis	0.001	0.998	0.000
I51.8 Other ill-defined heart diseases	0.000	0.998	0.002
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium	0.000	0.998	0.002
W29.5 Trade and service area	0.002	0.998	0.000
H18.5 Hereditary corneal dystrophies	0.002	0.998	0.000
H74.4 Polyp of middle ear	0.002	0.998	0.000
N83.3 Acquired atrophy of ovary and Fallopian tube	0.000	0.998	0.002
Z46.5 Fitting and adjustment of ileostomy and other intestinal appliances	0.002	0.998	0.000
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium	0.000	0.998	0.002
N42.1 Congestion and haemorrhage of prostate	0.002	0.998	0.000
N64.8 Other specified disorders of breast	0.002	0.998	0.000
O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium	0.000	0.998	0.002
T51.0 Ethanol	0.002	0.998	0.000
U81 Agent resistant to vancomycin and related antibiotics	0.000	0.998	0.002
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.002	0.998	0.000
N87.2 Severe cervical dysplasia, not elsewhere classified	0.000	0.998	0.002
H18.4 Corneal degeneration	0.002	0.998	0.000
N71.1 Chronic inflammatory disease of uterus	0.000	0.998	0.002
W29.8 Other specified place	0.002	0.998	0.000
W29.6 Industrial and construction area	0.002	0.998	0.000
W29.0 Home	0.002	0.998	0.000
W29.7 Farm	0.002	0.998	0.000
W29.4 Street and highway	0.002	0.998	0.000
W29.3 Sports and athletics area	0.002	0.998	0.000
W29.2 School, other institution and public administrative area	0.002	0.998	0.000
W29.1 Residential institution	0.002	0.998	0.000
D47.1 Chronic myeloproliferative disease	0.000	0.998	0.002
H65.4 Other chronic nonsuppurative otitis media	0.001	0.998	0.000
U80.0 Penicillin resistant agent	0.000	0.998	0.002
J32.0 Chronic maxillary sinusitis	0.000	0.998	0.002
J33.8 Other polyp of sinus	0.000	0.998	0.002
R45.1 Restlessness and agitation	0.001	0.998	0.000
D80-D89 Certain disorders involving the immune mechanism	0.002	0.998	0.000
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.000	0.998	0.002
H66.3 Other chronic suppurative otitis media	0.001	0.998	0.000
U81.0 Vancomycin resistant agent	0.000	0.998	0.002
C18.7 Sigmoid colon	0.000	0.998	0.002
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.001	0.998	0.000
H18.8 Other specified disorders of cornea	0.002	0.998	0.000
N80.3 Endometriosis of pelvic peritoneum	0.000	0.998	0.002
U50 Level of care administered to neonates	0.000	0.998	0.001
U07 Emergency use of U07	0.000	0.998	0.001
U06 Emergency use of U06	0.000	0.998	0.001
U04 Severe acute respiratory syndrome [SARS]	0.000	0.998	0.001
U52 First in a series of a regular day/night admissions	0.000	0.998	0.001
D86.8 Sarcoidosis of other and combined sites	0.001	0.998	0.000
H73.9 Disorder of tympanic membrane, unspecified	0.001	0.998	0.000
H73.1 Chronic myringitis	0.001	0.998	0.000
H73.0 Acute myringitis	0.001	0.998	0.000
I24 Other acute ischaemic heart diseases	0.000	0.998	0.002
R42 Dizziness and giddiness	0.000	0.998	0.002
C34.9 Bronchus or lung, unspecified	0.002	0.998	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.001	0.998	0.000
D80.8 Other immunodeficiencies with predominantly antibody defects	0.001	0.998	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.001	0.998	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.001	0.998	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.001	0.998	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations